Antibody-drug Conjugate Information
General Information of This Antibody-drug Conjugate (ADC)
| ADC ID |
DRG0HHEYM
|
|||||
|---|---|---|---|---|---|---|
| ADC Name |
DXC-007
|
|||||
| Synonyms |
DXC-007; DXC 007; DXC007
Click to Show/Hide
|
|||||
| Organization |
Hangzhou DAC Biotech Co., Ltd.
|
|||||
| Drug Status |
Phase 1
|
|||||
| Indication |
In total 1 Indication(s)
|
|||||
| Drug-to-Antibody Ratio |
Undisclosed
|
|||||
| Antibody Name |
A recombinant humanized anti-CD33 monoclonal antibody
|
Antibody Info | ||||
| Antigen Name |
Myeloid cell surface antigen CD33 (CD33)
|
Antigen Info | ||||
| Payload Name |
Tubulysin B analog Tub255
|
Payload Info | ||||
| Therapeutic Target |
Microtubule (MT)
|
Target Info | ||||
| Linker Name |
Undisclosed
|
|||||
| Conjugate Type |
Random Cysteines
|
|||||
